{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:59:58Z","timestamp":1789775998787,"version":"4.0.1"},"reference-count":49,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Accessibility of pre\u2010exposure prophylaxis (PrEP) in Canada remains complex as publicly funded coverage and delivery differs by province. In January 2018, PrEP became publicly funded and free of charge in British Columbia (BC), whereas PrEP coverage in Ontario and Montreal is more limited and may require out\u2010of\u2010pocket costs. We examined differences over time in PrEP uptake and assessed factors associated with PrEP awareness and use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Gay, bisexual and other men who have sex with men (GBM) were recruited through respondent\u2010driven sampling (RDS) in Toronto, Vancouver and Montreal, Canada, in a prospective biobehavioural cohort study. We applied generalized estimating equations with hierarchical data (RDS chain, participant, visit) to examine temporal trends of PrEP use and correlates of PrEP awareness and use from 2017 to 2020 among self\u2010reported HIV\u2010negative\/unknown GBM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 2008 self\u2010identified HIV\u2010negative\/unknown GBM at baseline, 5093 study visits were completed from February 2017 to March 2020. At baseline, overall PrEP awareness was 88% and overall PrEP use was 22.5%. During our study period, we found PrEP use increased in all cities (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001): Montreal 14.2% during the first time period to 39.3% during the last time period (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001), Toronto 21.4\u201331.4% (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001) and Vancouver 21.7\u201359.5% (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001). Across the study period, more Vancouver GBM used PrEP than Montreal GBM (aOR = 2.05, 95% CI = 1.60\u20132.63), with no significant difference between Toronto and Montreal GBM (aOR = 0.90, 95% CI = 0.68\u20131.18).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Full free\u2010of\u2010charge public funding for PrEP in BC likely contributed to differences in PrEP awareness and use. Increasing public funding for PrEP will improve accessibility and uptake among GBM most at risk of HIV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jia2.26017","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T12:58:47Z","timestamp":1666961927000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Examining provincial PrEP coverage and characterizing PrEP awareness and use among gay, bisexual and other men who have sex with men in Vancouver, Toronto and Montreal, 2017\u20132020"],"prefix":"10.1002","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5649-0326","authenticated-orcid":false,"given":"Jordan M.","family":"Sang","sequence":"first","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"McAllister","sequence":"additional","affiliation":[{"name":"School of Public Health and Social Policy University of Victoria  Victoria British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Barath","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Lal","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbie","family":"Parlette","sequence":"additional","affiliation":[{"name":"Ryerson University  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed W.","family":"Noor","sequence":"additional","affiliation":[{"name":"Ryerson University  Toronto Ontario Canada"},{"name":"School of Human Sciences Louisiana State University Shreveport  Shreveport Louisiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herak","family":"Apelian","sequence":"additional","affiliation":[{"name":"McGill University  Montr\u00e9al Quebec Canada"},{"name":"Direction r\u00e9gionale de sant\u00e9 publique \u2010Montr\u00e9al CIUSSS Centre\u2010Sud\u2010de\u2010l'Ile\u2010de\u2010Montr\u00e9al  Montr\u00e9al Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Skakoon\u2010Sparling","sequence":"additional","affiliation":[{"name":"Ryerson University  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hull","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"},{"name":"University of British Columbia  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1078-9247","authenticated-orcid":false,"given":"David M.","family":"Moore","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"},{"name":"University of British Columbia  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cox","sequence":"additional","affiliation":[{"name":"McGill University  Montr\u00e9al Quebec Canada"},{"name":"Direction r\u00e9gionale de sant\u00e9 publique \u2010Montr\u00e9al CIUSSS Centre\u2010Sud\u2010de\u2010l'Ile\u2010de\u2010Montr\u00e9al  Montr\u00e9al Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor A.","family":"Hart","sequence":"additional","affiliation":[{"name":"Ryerson University  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lambert","sequence":"additional","affiliation":[{"name":"Direction r\u00e9gionale de sant\u00e9 publique \u2010Montr\u00e9al CIUSSS Centre\u2010Sud\u2010de\u2010l'Ile\u2010de\u2010Montr\u00e9al  Montr\u00e9al Quebec Canada"},{"name":"Institut national de sant\u00e9 publique du Qu\u00e9bec  Montr\u00e9al Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grace","sequence":"additional","affiliation":[{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Jollimore","sequence":"additional","affiliation":[{"name":"Community Based Research Centre  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Hogg","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"},{"name":"Simon Fraser University  Burnaby British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Lachowsky","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS  Vancouver British Columbia Canada"},{"name":"School of Public Health and Social Policy University of Victoria  Victoria British Columbia Canada"},{"name":"Community Based Research Centre  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Public Health Agency of Canada.HIV in Canada: 2020 Surveillance Highlights.2021. Available from:https:\/\/www.canada.ca\/en\/public\u2010health\/services\/publications\/diseases\u2010conditions\/hiv\u20102020\u2010surveillance\u2010highlights.html. Accessed on 15 October 2021."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20200198"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i12a05"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v45i12a01"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2016.1146653"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"e_1_2_11_8_1","unstructured":"Government of Canada.Regulatory Decision Summary \u2010 TRUVADA \u2010 Health Canada.2020[cited 2021 Feb 3]. Available from:https:\/\/hpr\u2010rps.hres.ca\/reg\u2010content\/regulatory\u2010decision\u2010summary\u2010detail.php?linkID=RDS00107"},{"key":"e_1_2_11_9_1","article-title":"Trends in HIV pre\u2010exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population\u2010based analysis of projected pharmacy data (2015\u20132018)","author":"Tan DHS","year":"2020","journal-title":"Can J Public Health"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2019.93"},{"key":"e_1_2_11_11_1","unstructured":"Government of Canada.Federal public drug benefit programs.2019. Available from:https:\/\/www.canada.ca\/en\/health\u2010canada\/services\/health\u2010care\u2010system\/pharmaceuticals\/access\u2010insurance\u2010coverage\u2010prescription\u2010medicines\/federal\u2010public\u2010drug\u2010benefit\u2010programs.html. Accessed on 15 October 2021."},{"key":"e_1_2_11_12_1","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS.Guidance for the use of pre\u2010exposure prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia.2020. Available from:http:\/\/www.bccfe.ca\/sites\/default\/files\/uploads\/publications\/centredocs\/prep_guidelines_17\u2010jun\u20102020.pdf. Accessed on 15 October 2021."},{"key":"e_1_2_11_13_1","unstructured":"YoongD.Provincial\/territorial coverage of ARV drugs for HIV prevention across Canada: post\u2010exposure prophylaxis (PEP) and pre\u2010exposure prophylaxis (PrEP).2019. Available from:https:\/\/hivclinic.ca\/wp\u2010content\/uploads\/2018\/04\/ARV\u2010Coverage_PEP\u2010and\u2010PrEP.pdf. Accessed on 15 October 2021."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1675-z"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-018-0090-1"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v45i11a01"},{"key":"e_1_2_11_17_1","unstructured":"Public Health Agency of Canada.Trends in HIV pre\u2010exposure prophylaxis use. An analysis of prescription data in eight Canadian provinces 2016\u20132020.2021. Available from:https:\/\/www.canada.ca\/en\/public\u2010health\/services\/publications\/diseases\u2010conditions\/hiv\u2010trends\u2010pre\u2010exposure\u2010prophylaxis\u2010canadian\u2010provinces\u20102016\u20102020.html. Accessed on 15 October 2021."},{"key":"e_1_2_11_18_1","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS.HIV Pre\u2010Exposure Prophylaxis (PrEP) Semi\u2010Annual Report for British Columbia Second Quarter 2021.2021. Available from:http:\/\/bccfe.ca\/sites\/default\/files\/uploads\/publications\/centredocs\/prep_qmr_report_q2_2021.pdf. Accessed on 15 October 2021."},{"key":"e_1_2_11_19_1","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS.HIV Pre\u2010Exposure Prophylaxis (PREP) Quarterly Report for British Columbia Second Quarter 2019.2020. Available from:http:\/\/bccfe.ca\/sites\/default\/files\/uploads\/publications\/centredocs\/prep_indicators_report_220620201.pdf. Accessed on 15 October 2021."},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25699"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.2307\/3096941"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-021-00546-z"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318256b2f6"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-statistics-031017-100704"},{"issue":"1","key":"e_1_2_11_25_1","first-page":"79","article-title":"Probability based estimation theory for respondent driven sampling","volume":"24","author":"Volz E","year":"2008","journal-title":"J Off Stat"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181f2ac87"},{"issue":"3","key":"e_1_2_11_27_1","first-page":"110","article-title":"Treatment as prevention: toward an AIDS\u2010free generation","volume":"21","author":"Montaner JSG","year":"2013","journal-title":"Top Antiviral Med"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087872"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.2018.30.5.369"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy182"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/JNC.0000000000000105"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20200198"},{"key":"e_1_2_11_33_1","unstructured":"World Health Organization.Global data shows increasing PrEP use and widespread adoption of WHO PrEP recommendations.2021. Available from:https:\/\/www.who.int\/news\u2010room\/feature\u2010stories\/detail\/global\u2010data\u2010shows\u2010increasing\u2010prep\u2010use\u2010and\u2010widespread\u2010adoption\u2010of\u2010who\u2010prep\u2010recommendations#:~:text=Data%20compiled%20by%20the%20Global a%2070%25%20increase%20from%202018"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2368-y"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25461"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30186-9"},{"issue":"1481","key":"e_1_2_11_37_1","first-page":"64","article-title":"Implementing HIV pre\u2010exposure prophylaxis (PrEP): let's not get caught with our pants down","volume":"131","author":"Saxton PJ","year":"2018","journal-title":"NZ Med J"},{"key":"e_1_2_11_38_1","unstructured":"SandsetTJ.PrEP at the margins: towards a critically applied anthropology of nordic PrEP access. A \u2018critically applied\u2019 approach to PrEP2019[cited 2022 May 27]. Available from:http:\/\/somatosphere.net\/2019\/prep\u2010at\u2010the\u2010margins\u2010towards\u2010a\u2010critically\u2010applied\u2010anthropology\u2010of\u2010nordic\u2010prep\u2010access.html\/"},{"key":"e_1_2_11_39_1","unstructured":"Health Protection Scotland.Implementation of HIV PrEP in Scotland: first year report.2019. Available from:https:\/\/www.hps.scot.nhs.uk\/web\u2010resources\u2010container\/implementation\u2010of\u2010hiv\u2010prep\u2010in\u2010scotland\u2010first\u2010year\u2010report\/. Accessed on 3 November 2021."},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002790"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00112-2"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2020.1739219"},{"key":"e_1_2_11_43_1","unstructured":"British Columbia Centre for Disease Control.Reportable Diseases Data Dashboard.2022. Available from:http:\/\/www.bccdc.ca\/health\u2010professionals\/data\u2010reports\/reportable\u2010diseases\u2010data\u2010dashboard. Accessed on 18 October 2021."},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002613"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25632"},{"key":"e_1_2_11_46_1","unstructured":"Public Health Agency of Canada.Funding opportunities to address sexually transmitted and blood\u2010borne infections (STBBI).2021[cited 2022 June 17]. Available from:https:\/\/www.canada.ca\/en\/public\u2010health\/services\/funding\u2010opportunities\/sexually\u2010transmitted\u2010blood\u2010borne\u2010infections.html"},{"key":"e_1_2_11_47_1","unstructured":"HIV Legal Network.Funding the fight: supporting and sustaining the federal response to HIV and AIDS in Canada.2021."},{"key":"e_1_2_11_48_1","volume-title":"Edmiston: as HIV funding goes down, HIV infections in Canada increase. We can stop this","author":"Edmiston L","year":"2021"},{"key":"e_1_2_11_49_1","unstructured":"U.S. Federal Funding.Federal Funding for HIV\/AIDS: trends over time.2019[cited 2022 May 27]. Available from:https:\/\/files.kff.org\/attachment\/Fact\u2010Sheet\u2010US\u2010Federal\u2010Funding\u2010for\u2010HIVAIDS\u2010Trends\u2010Over\u2010Time."},{"key":"e_1_2_11_50_1","unstructured":"Gov.Uk.Over \u00a323 million investment to end new HIV infections by 2030.Department of Health and Social Care;2021."}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.26017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.26017","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.26017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T04:49:12Z","timestamp":1692593352000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.26017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1002\/jia2.26017"],"URL":"https:\/\/doi.org\/10.1002\/jia2.26017","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.32920\/25460890","asserted-by":"object"},{"id-type":"doi","id":"10.32920\/25460890.v1","asserted-by":"object"}]},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e26017"}}